In this work a new series of P-glycoprotein and CA XII inhibitor hybrids was synthesized and studied for their ability to reverse the P-gp mediated MDR in cancer cells, which overexpressed both the transmembrane P-gp and CA XII proteins. The gene discussed is PGP; the disease is cancer.